The cool thing about this is that the JV is big enough (see stats on Chinese market alone) that it could give the company enough cash to get the CareBot into the market in spite of the NSS.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.